TOBREX

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0078-0813
  • Package NDC 0078-0813-01
  • Application number NDA050555
  • SPL ID 8ea30c53-668e-48f2-a1b8-d4eab73d7ecb
  • SPL set ID 5b66bba3-cf97-4a9c-b618-ba5f277f20f6
  • UNII VZ8RRZ51VK
  • RxCUI 207850
  • RxCUI 313414

What the source publishes

Labeler
Novartis Pharmaceuticals Corporation
Active ingredients
tobramycin
Form
OINTMENT
Routes
OPHTHALMIC
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0078-0813_8ea30c53-668e-48f2-a1b8-d4eab73d7ecb
{
  "name": "TOBREX",
  "splId": "8ea30c53-668e-48f2-a1b8-d4eab73d7ecb",
  "labels": [
    {
      "setId": "5b66bba3-cf97-4a9c-b618-ba5f277f20f6",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b66bba3-cf97-4a9c-b618-ba5f277f20f6",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b66bba3-cf97-4a9c-b618-ba5f277f20f6"
    }
  ],
  "routes": [
    "OPHTHALMIC"
  ],
  "labeler": "Novartis Pharmaceuticals Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "3.5 g in 1 TUBE (0078-0813-01)",
      "package_ndc": "0078-0813-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220308"
    }
  ],
  "productId": "0078-0813_8ea30c53-668e-48f2-a1b8-d4eab73d7ecb",
  "useDomain": "unknown",
  "dosageForm": "OINTMENT",
  "productNdc": "0078-0813",
  "deaSchedule": null,
  "genericName": "tobramycin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOBRAMYCIN",
      "strength": "3 mg/g"
    }
  ],
  "applicationNumber": "NDA050555",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19810628",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175477",
      "M0000946"
    ],
    "unii": [
      "VZ8RRZ51VK"
    ],
    "rxcui": [
      "207850",
      "313414"
    ],
    "spl_set_id": [
      "5b66bba3-cf97-4a9c-b618-ba5f277f20f6"
    ],
    "pharm_class_cs": [
      "Aminoglycosides [CS]"
    ],
    "pharm_class_epc": [
      "Aminoglycoside Antibacterial [EPC]"
    ],
    "manufacturer_name": [
      "Novartis Pharmaceuticals Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0078-0813_8ea30c53-668e-48f2-a1b8-d4eab73d7ecb"